87 results
8-K
EX-99.2
kwlpxass9lb ea37fbkk
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
lqx4fvo
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
g7qo03
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-99.1
wycmph3n58
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-10.1
y0bmyo
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
bdtrskm
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-10.1
65c3cil yre
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am